Research · Source update
Does diabetes status matter when reading obesity trials?
Source context: Read the linked original research or registry entry for study status and limitations.
In the September TRIUMPH-1 paper, the research team focused on adults living with obesity who did not have diabetes. That choice was intentional: clinical trials define their participants to answer a particular question. We explain why the population matters and why an impressive average from one trial cannot automatically be applied to everyone.
Which participants were studied
In the September TRIUMPH-1 paper, the research team focused on adults living with obesity who did not have diabetes. That choice was intentional: clinical trials define their participants to answer a particular question. We explain why the population matters and why an impressive average from one trial cannot automatically be applied to everyone.
What does the original source show?
Participants with diabetes may have different background treatment and weight-change patterns. Results from trials with and without diabetes should not automatically be treated as equivalent.
Why does it matter?
Researchers often set enrollment rules so they can answer a focused question. For example, a trial might include people with obesity but not diabetes. That improves clarity for that group, yet it limits what we can assume for someone who has diabetes or another condition not represented in the trial.
What should readers keep in mind?
You do not need to become a clinical researcher to spot this. Look for the 'participants' or 'population' section and read the eligibility description before the results chart. If two articles describe similar drugs but different patient groups, the difference in percentages may come from the studies rather than the drugs alone.
The practical takeaway
Check a study's inclusion criteria before assuming its mean is relevant to you.
The bottom line
Check a study's inclusion criteria before assuming its mean is relevant to you.
Written and published by MyDosePro as an educational explanation of publicly available evidence. The linked primary source is dated 2026-09-29. We identify trial registrations separately from published results and do not provide individual prescribing advice.
Primary sourceSource event or update: 2026-09-29. Our interpretation is educational and does not replace medical or insurance advice.